CMS issues new HCPCS codes for Dayspring, a novel wearable active compression treatment for lymphedema and venous diseases.
Lymphatic Research and Biology peer-reviewed journal publishes open-label controlled study evaluating efficacy of Dayspring.
OAKLAND, Calif., August 10, 2021 – Koya Medical, a healthcare company focused on developing breakthrough treatments for lymphedema and venous diseases, announced today that its wearable, active compression therapy system for lymphedema—Dayspring™— was issued new billing codes by the Center of Medicare & Medicaid Services (CMS) in accordance with the Healthcare Common Procedure Coding System (HCPCS). Dayspring is the first wearable and mobility-enabling active compression treatment cleared by the U.S. Food & Drug Administration (FDA) to treat lymphedema and other similar conditions. Providers may begin using the new codes on…